期刊文献+

聚乳酸-乙醇酸/纳米氧化锌复合电纺纤维装载亲疏水药物的控释及体外细胞毒性 被引量:3

Controlled Release of Multiple Hydrophilic and Hydrophobic Drugs and in vitro Cytotoxicity of Electrospun Poly( lactic-co-glycolic acid) /ZnO Nanofibers Encapsulated with Dual Drugs
下载PDF
导出
摘要 利用静电纺丝技术制备了负载亲水性药物阿霉素(DOX)以及疏水性药物喜树碱(CPT)的复合纳米纤维.先用巯基封端的普朗尼克(F127)修饰纳米氧化锌(FZnO),再将FZnO负载盐酸阿霉素(DOX@FZnO),最后将DOX@FZnO与CPT一起纺入聚乳酸-乙醇酸(PLGA)纤维中.体外药物释放结果表明,复合纳米纤维能够减小亲水性药物的突释,减缓药物释放速率,延长药物释放时间.体外细胞活性结果表明,双载药复合纤维比单载药复合纤维具有更强的细胞毒性,能够有效抑制癌细胞生长. A novel poly( lactic-co-glycolic acid) ( PLGA)/ZnO electrospun composite fibers encapsulated with both hydrophilic drug(doxorubicin hydrochloride, DOX) and hydrophobic drug(camptothecin, CPT) were fabricated via electrospinning method. Primarily, the ZnO was decorat with F127 and then used to encapsulate DOX. Finally, the DOX-loaded ZnO( DOX@ZnO) and CPT were mixed with PLGA solution to fabricate elec-trospun hybrid nanofibers. The in vitro release results demonstrated the composite fibers decreased the burst release and increased the time of release, which showed a long-term and sustained release. The cell cytotoxici-ty test demonstated that the composite nanofiber with two drugs showed stronger antitumor efficacy against HepG-2 cells than the nanofiber with single drug. Thus, the composite nanofibers with two anticancer drugs could be a versatile drug delivery system as local implantable scaffolds for potential postsurgical cancer treat-ment.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2014年第8期1788-1794,共7页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:51203073) 江西省教育厅科学基金(批准号:GJJ13107)资助~~
关键词 静电纺丝 复合纳米纤维 氧化锌 药物控释 细胞毒性 聚乳酸-乙醇酸 Electrospinning Nanofibers ZnO Drug delivery Cytotoxicity Poly ( lactic-co-glycolic acid)
  • 相关文献

参考文献21

  • 1Xu X.L.,Chen X.S.,Wang Z.F.,Jing X.B.,Eur.J.Pharm.Biopharm.,2009,72(1),18-25.
  • 2Xiao Y.L.,Hong H.,Javadi A.,Emgle J.W.,Xu W.J,Yang Y.,Zhang Y.,Barnhart T.E.,Cai W.B.,Gong S.Q.,Biomaterials,2012,33(11),3071-3082.
  • 3Epler K.,Padilla D.,Phillips G.,Crowder P.,Castillo R.,Wilkinson D.,Wilkinson B.,Burgard C.,Kalinich R.,Townson J.,Chackerian B.,Willman C.,Peabody D.,Wharton W.,Brinker C.J.,Ashley C.,Carnes E.,Adv.Healthc.Mater.,2012,1(3),348-353.
  • 4Ahmed F.,Dische D.E.,J.Control.Release,2004,96(1),37-53.
  • 5Hu J.,Wei J.C.,Liu W.Y.,Chen Y.W.,J.Biomater.Sci.Polym.Ed.,2013,24(8),972-985.
  • 6Luo X.M.,Xie C.Y.,Wang H.,Liu C.Y.,Yan S.L.,Li X.H.,Int.J.Pharm.,2012,425(1/2),19-28.
  • 7Uhrich K.E.,Cannizzaro S.M.,Langer R.S.,Shakesheff K.M.,Chem.Rev.,1999,99(11),3181-3198.
  • 8Taepaiboon P.,Rungsardthong U.,Supaphol P.,Nanotechnology,2006,17,2317-2329.
  • 9Qiu K.X.,He C.L.,Feng W.,Wang W.Z.,Zhou X.J.,Yin Z.Q.,Chen L.,Wang H.S.,Mo X.M.,J.Mater.Chem.B,2013,1,4601-4611.
  • 10Wei L.,Cai C.H.,Lin J.P.,Chen T.,Biomaterials,2009,30(13),2606-2613.

同被引文献52

  • 1傅和青,张心亚,黄洪,沈慧芳,蓝仁华,陈焕钦.乳液聚合法制备聚苯胺及其导电性能[J].化工学报,2005,56(9):1790-1793. 被引量:16
  • 2徐昌洪,方家骥.L-乳酸生物炼制技术的新进展[J].精细与专用化学品,2007,15(14):10-13. 被引量:3
  • 3史高峰,王国英.L(+)-乳酸发酵与分离技术研究进展[J].食品科学,2007,28(12):547-551. 被引量:8
  • 4Soussan E. , Cassel S. , Blanzat M. , Rico-Lattes I. , Angew. Chem. Int. Ed. , 2009, 48(2), 274-288.
  • 5Timko B. P. , Dvir T. , Kohane D. S. , Adv. Mater. , 2010, 22(44), 4925--4943.
  • 6He C. , Zhuang X. , Tang Z. , Tian H. , Chen X. , Adv. Healthcare Mater. , 2012, 1 ( 1 ), 48-78.
  • 7Yokoyama M. , Expert Opia. D:g Oeliv. , 2010, 7(2) , 145-158.
  • 8Akimoto J. , Nakayama M. , Okano T. , J. Control Release, 2014, 193, 2-8.
  • 9MAN., LiY., XuH., WangZ. , ZhangX., J. Am. Chem. Soe. ,2010, 132(2),442--443.
  • 10Bozzuto G. , Molinari A. , Int. J. Nanomedicine, 2015, 10, 975-999.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部